EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics

Jessica D Podoll, Emma Rosen, Wei Wang, Yuefeng Gao, Jing Zhang, Xiang Wang iD

Antimicrobial Agents and Chemotherapy · 18.10.2023 · 67 (10)

DOI: 10.1128/aac.00051-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 18.10.2023. Verfasst von Jessica D Podoll und 5 weiteren Autor:innen. Beteiligte Einrichtung: Recreo Pharmaceuticals Inc, Yale Circle , Boulder, Colorado, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel antibacterial agents and strategies are urgently needed to fight against the ongoing global antibiotic resistance problem. While natural products remain the main source in antibiotic discovery, synthetic antibacterials provide an attractive alternative and may evade the ancient antibiotic resistance. Herein, we report a small molecule that re-sensitizes methicillin-resistant Staphylococcus aureus to β-lactam antibiotics with extremely low potential for resistance development. It belongs to a new class of broad-spectrum antibacterials, trypyricins, which share similar structural characteristics and mechanism of action to the cationic antimicrobial peptides. Mechanistic studies indicated that trypyricins fluidize and disrupt bacterial cytoplasmic membrane. These results suggested that trypyricins represent a promising new class of antibacterials and may be further developed as antibiotic adjuvants to fight against resistant bacteria in the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsAnti-Bacterial AgentsMonobactamsDrug Resistance, Microbial

Stichwörter der Autor:innen

antibioticantibiotic adjuvantantimicrobial resistancemembrane fluidizer

Substanzen

Anti-Bacterial AgentsMonobactams

Autor:innen und Institutionen

  • Recreo Pharmaceuticals Inc, Yale Circle , Boulder, Colorado, USA.
  • Department of Chemistry, University of Colorado , Boulder, Colorado, USA.

ORCID-Profile: Xiang Wang

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Podoll, J. D., Rosen, E., Wang, W., Gao, Y., Zhang, J., & Wang, X. (2023). A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy, 67(10). https://doi.org/10.1128/aac.00051-23

Vancouver

Podoll JD, Rosen E, Wang W, Gao Y, Zhang J, Wang X. A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 2023;67(10). doi:10.1128/aac.00051-23

BibTeX
@article{Podoll2023,
  author = {Podoll, Jessica D and Rosen, Emma and Wang, Wei and Gao, Yuefeng and Zhang, Jing and Wang, Xiang},
  title = {A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  volume = {67},
  number = {10},
  doi = {10.1128/aac.00051-23}
}
Kostenlos starten →